Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD
Launched by SHANDONG UNIVERSITY · Mar 19, 2025
Trial Information
Current as of April 22, 2025
Active, not recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with Crohn's disease undergoing endoscopic examination
- • Healthy individuals with no symptoms undergoing colonoscopy without any lesions detected
- • Patients undergoing small intestinal endoscopy due to symptoms but with negative examination results.
- • Age between 18 and 80 years.
- • Patients or authorized family members sign the relevant informed consent forms.
- Exclusion Criteria:
- • Patients with concurrent digestive system diseases that may affect the study results, including tumors, infections, or other autoimmune diseases.
- • Patients with concurrent non-digestive system diseases that may affect the study results, including tumors, infections, or autoimmune diseases.
- • Patients who have taken probiotics or antibiotics within the past week.
- • Patients with psychiatric disorders or other conditions that prevent them from cooperating with the study.
- • Patients participating in other clinical trials that may interfere with the results of this study.
Trial Officials
Xiuli Zuo, doctor
Study Director
Qilu Hospital of Shandong University
About Shandong University
Shandong University is a prestigious research institution located in Jinan, China, renowned for its commitment to advancing medical and scientific knowledge through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment conducive to groundbreaking studies that address critical healthcare challenges. Shandong University actively engages in clinical research to evaluate new therapies and interventions, contributing to the global body of medical literature and enhancing patient care. Its dedicated team of researchers and clinicians ensures adherence to the highest ethical standards and regulatory compliance, positioning the university as a key player in the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported